Trial Profile
Cabozantinib in women with with advanced ovarian cancer with stable disease from prior cabozantinib
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 24 Jun 2011
Price :
$35
*
At a glance
- Drugs Cabozantinib (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- 24 Jun 2011 New trial record